Lina Khan, FTC chair (Graeme Sloan/Sipa USA)(Sipa via AP Images)
February 14, 2024 03:51 PM EST
Pharma
FDA+

Biden ad­min­is­tra­tion tar­gets GPOs, whole­salers in re­quest for in­for­ma­tion on gener­ic short­ages

Lia DeGroot

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Unit­ed­Health Group CEO An­drew Wit­ty steps down

TIG­IT grave­yard ex­pands as GSK drops late-stage as­set with iTeos

CRISPR patent spat re­vived by fed­er­al ap­peals court rul­ing

Bay­er starts 2025 by cut­ting 2,000 jobs as it homes in on year-end re­haul tar­get

HHS fo­cus­es on 'trans­paren­cy' in third-round IRA ne­go­ti­a­tion guid­ance

Some gener­ics, biosim­i­lar drug­mak­ers say they can with­stand tar­iff im­pact

A service from the Financial Times